A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial.

Berkenblit, Anna

A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. [electronic resource] - Gynecologic oncology Oct 2005 - 50-7 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article

0090-8258

10.1016/j.ygyno.2005.05.023 doi


Aged
Amino Acid Sequence
Antineoplastic Agents--administration & dosage
Biomarkers, Tumor--blood
Dose-Response Relationship, Drug
Female
Genital Neoplasms, Female--blood
Humans
Injections, Subcutaneous
Middle Aged
Molecular Sequence Data
Peptide Fragments--administration & dosage
Urokinase-Type Plasminogen Activator--administration & dosage